Tonix Pharmaceuticals Holding (TNXP) FCF Margin (2022 - 2026)

Tonix Pharmaceuticals Holding has reported FCF Margin for 5 years, with the latest figure at 301.09% in Q2 2026.

• On a quarterly basis, FCF Margin rose 46768.0% year-over-year to 301.09% in Q2 2026; TTM through Jun 2026 was 543.29%, a 12183.0% increase from a year earlier, with the FY2025 full-year figure at 787.46%, down 18270.0% from the prior year.
• FCF Margin was 301.09% for Q2 2026 at Tonix Pharmaceuticals Holding, up from 669.67% in the prior quarter.
• The five-year high for FCF Margin was 301.09% in Q2 2026, with the low at 904.07% in Q3 2025.
• Average FCF Margin over 5 years is 671.98%, with a median of 682.79% recorded in 2025.
• The sharpest annual moves came in 2025 and 2026: FCF Margin tumbled 31954 bps in 2025, then jumped 46768 bps in 2026.
• Over 5 years, FCF Margin stood at 890.1% in 2022, then soared by 32 bps to 602.75% in 2023, then grew by 6 bps to 566.73% in 2024, then slumped by 36 bps to 770.39% in 2025, then soared by 61 bps to 301.09% in 2026.
• The last three FCF Margin figures came in at 301.09% (Q2 2026), 669.67% (Q1 2026), and 770.39% (Q4 2025), per Business Quant data.